Dozens of women have filed suit against a drug company that they claim sold them defective birth control that led to unplanned pregnancies.

Qualitest, a subsidiary of the Irish-based Endo Pharmaceuticals, is now facing a class action lawsuit filed in a Pennsylvania state court last week. It has been joined by 113 women in 26 states who say they became pregnant because of improperly packaged oral contraceptive pills in 2011.

ADVERTISEMENT

The drug company issued a recall in 2011 after learning that its manufacturer had put some birth control pills into packages upside down — reversing the order of the hormone pills and putting women at risk for pregnancy.

The women are seeking millions in damages for the costs of delivering and raising their children.

Of the 113 women, 94 carried their pregnancies to term, including several teenagers, according to a 2012 story by The Atlantic. At least one client gave up her child for adoption because she was about to be deployed in the military, while others said they dropped out of law school and nursing school, The Atlantic reported.

The women had previously tried to file suit in an Atlanta court, seeking $5 million in damages, but their request had been rejected.

A similar blunder was made by pharmaceutical giant Pfizer in 2012, in which 1 million birth control packs were recalled because of out-of-sequence pills.